全文获取类型
收费全文 | 60837篇 |
免费 | 5841篇 |
国内免费 | 2035篇 |
专业分类
耳鼻咽喉 | 464篇 |
儿科学 | 1349篇 |
妇产科学 | 564篇 |
基础医学 | 4454篇 |
口腔科学 | 488篇 |
临床医学 | 6807篇 |
内科学 | 14341篇 |
皮肤病学 | 339篇 |
神经病学 | 564篇 |
特种医学 | 2763篇 |
外国民族医学 | 44篇 |
外科学 | 6571篇 |
综合类 | 11558篇 |
现状与发展 | 10篇 |
预防医学 | 2192篇 |
眼科学 | 184篇 |
药学 | 4752篇 |
47篇 | |
中国医学 | 2109篇 |
肿瘤学 | 9113篇 |
出版年
2024年 | 61篇 |
2023年 | 990篇 |
2022年 | 1430篇 |
2021年 | 2636篇 |
2020年 | 2701篇 |
2019年 | 2329篇 |
2018年 | 2259篇 |
2017年 | 2478篇 |
2016年 | 2654篇 |
2015年 | 2879篇 |
2014年 | 4452篇 |
2013年 | 4479篇 |
2012年 | 3889篇 |
2011年 | 4011篇 |
2010年 | 3313篇 |
2009年 | 3024篇 |
2008年 | 2935篇 |
2007年 | 2922篇 |
2006年 | 2712篇 |
2005年 | 2451篇 |
2004年 | 1968篇 |
2003年 | 1753篇 |
2002年 | 1450篇 |
2001年 | 1253篇 |
2000年 | 1103篇 |
1999年 | 929篇 |
1998年 | 758篇 |
1997年 | 649篇 |
1996年 | 553篇 |
1995年 | 539篇 |
1994年 | 474篇 |
1993年 | 362篇 |
1992年 | 340篇 |
1991年 | 259篇 |
1990年 | 251篇 |
1989年 | 198篇 |
1988年 | 186篇 |
1987年 | 164篇 |
1986年 | 140篇 |
1985年 | 171篇 |
1984年 | 145篇 |
1983年 | 79篇 |
1982年 | 76篇 |
1981年 | 73篇 |
1980年 | 67篇 |
1979年 | 46篇 |
1978年 | 32篇 |
1977年 | 26篇 |
1976年 | 22篇 |
1975年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
傅自萍 《中国继续医学教育》2021,(5)
目的探析慢性阻塞性肺疾病合并侵袭性肺曲霉菌病患者的临床特点。方法对医院2018年2月—2019年12月间收治的慢性阻塞性肺疾病合并侵袭性肺曲霉菌病患者24例相关临床数据进行回顾性分析,归纳此类患者的临床特点,以期为以后收治此类患者在诊疗上提供可参考数据。结果慢性阻塞性肺疾病合并侵袭性肺曲霉菌病患者典型临床症状为肺部罗音、呼吸障碍、胸痛、咳嗽咳痰、发热。影像学检查后典型表现为肺部炎性渗出、空洞、结节、实变。经过积极治疗后有8例患者判定为治疗有效。结论收治慢性阻塞性肺疾病合并侵袭性肺曲霉菌病患者应该做到早期阶段准确诊断,积极治疗,是保障预后的重点。 相似文献
82.
目的分析雾化吸入布地奈德治疗慢性阻塞性肺疾病急性加重(AECOPD)合并2型糖尿病(T2DM)患者疗效及对肺通气功能和糖代谢指标的影响。 方法选择四川大学华西医院2019年1月至2020年5月诊治的120例AECOPD合并T2DM患者作为对象,根据非随机临床同期对照研究及患者自愿原则分为对照组58例和观察组62例,其中对照组给予低剂量布地奈德治疗,观察组给予高剂量布地奈德治疗。比较两组患者治疗前后肺通气功能、糖代谢指标和炎性因子水平变化,并评估疗效和安全性。 结果两组患者治疗有效率比较无显著差异(P>0.05);与治疗前比,两组患者治疗后肺通气功能指标均显著升高,但观察组较对照组升高更为显著(P<0.05);两组患者之间及其治疗前后糖代谢指标均无显著差异(P>0.05);与治疗前比,两组患者治疗后炎症因子水平均显著降低,但观察组较对照组降低更为显著(P<0.05);两组不良反应发生率比较无统计学意义(P>0.05)。 结论布地奈德雾化吸入治疗AECOPD合并T2DM安全有效,对糖代谢指标无明显影响,但高剂量的布地奈德对于患者肺通气功能和炎症水平改善效果更好。 相似文献
83.
84.
Yi Zhao Qianqian Zhang Helin Feng Xiyan Zhu 《The Journal of international medical research》2021,49(4)
The incidence of tumours found in the patella, including primary and metastatic tumours, is low. Solitary metastasis of oesophageal carcinoma (OC) in the patella is even rarer. A 50-year-old man presented to our clinic because of pain and limited range of motion in the right knee for 4 hours and after a fall. On the basis of the patient’s medical history, he was diagnosed with OC 2 months previously and underwent two cycles of paclitaxel liposome combined with tiggio chemotherapy (oral tiggio, 40 mg, two times/day, with a treatment cycle of 3 weeks). A 99mTc-methylene diphosphonate bone scintigraphy scan showed increased radioactivity in the right patella. A right knee biopsy showed the presence of patellar metastasis from OC. Unfortunately, the patient denied additional treatment and was discharged for personal reasons. At the 1-month follow-up, which was conducted by a telephone survey, we learned that the patient had died of acute pulmonary embolism. X-rays and computed tomography are useful for diagnosing patellar metastases, but 99mTc-methylene diphosphonate bone scintigraphy can help physicians diagnose patellar metastasis of OC more rapidly. Biopsy with pathology is the gold standard for diagnosing patellar metastases. Additionally, timely surgical treatment prolongs the survival time of these patients. 相似文献
85.
86.
《Sleep medicine》2021
BackgroundWe aimed to assess mortality in chronic obstructive pulmonary disease (COPD), obstructive sleep apnea (OSA), and overlap syndrome, and evaluate which polysomnographic indices—apnea-hypopnea index (AHI) or hypoxemic load measurements—better predict mortality within 10 years.MethodsAdults with symptoms suggestive of sleep apnea and airway disease who underwent both polysomnography and spirometry plus bronchodilator response tests between 2000 and 2018 were included and divided into four groups according to presence of COPD and moderate-to-severe OSA (AHI ≥15/h). We estimated mortality using a Cox model adjusted for demographic/anthropometric covariates and comorbidities; this was called clinical model. To evaluate prognostic performance, we compared the concordance index (C-index) between clinical model and extended models, which incorporated one of polysomnographic indices—AHI, sleep time spent with SpO2 < 90% (TS90), and mean and lowest SpO2.ResultsAmong 355 participants, patients with COPD alone (57/355, 16.1%) and COPD–OSA overlap syndrome (37/355, 10.4%) had increased all-cause mortality than those who had neither disease (152/355, 42.8%) (adjusted HR, 2.98 and 3.19, respectively). The C-indices of extended models with TS90 (%) and mean SpO2 were significantly higher than that of clinical model (0.765 vs. 0.737 and 0.756 vs. 0.737, respectively; all P < 0.05); however, the C-index of extended model with AHI was not (0.739 vs. 0.737; P = 0.15).ConclusionsIn this cohort with symptoms of sleep apnea and airway disease, patients with overlap syndrome had increased mortality, but not higher than in those with COPD alone. The measurement of hypoxemic load, not AHI, better predicted mortality. 相似文献
87.
We aimed to retrospectively analyze the clinical and computed tomography (CT) characteristics of young adults with Coronavirus Disease 2019 (COVID-19) pneumonia who were critically ill and to identify the features associated with non-survival.Thirty-eight COVID-19 patients (20–45 years old, 28 men) who had been admitted in the intensive care unit were included, including 18 non-survivors (group 1) and 20 survivors (group 2). Their clinical characteristics and initial and follow-up CT were compared between groups.In group 1, the days from illness onset to death were 21.1 ± 10.3 days; 7 patients had underlying comorbidities. At admission, group 1 exhibited higher serum ferritin and interleukin-6 (IL-6) levels (1142.6 ± 242.4 mg/L and 33.8 ± 18.6 mmol/L) compared with group 2 (728.3 ± 150.9 mg/L and 15.2 ± 6.9 mmol/L, P < .01). Group 1 exhibited more rapidly progressive opacities and consolidation in follow-up CT (16.7 ± 3.1 scores, 15.7 ± 3.1 segments) than group 2 (11.4 ± 4.0 scores, 10.3 ± 4.6 segments, P < .01). The oxygenation index was lower (87.6 ± 19.2 vs 99.1 ± 20.4 mm Hg) and the mechanical ventilation duration was longer (14.7 ± 6.9 vs 9.7 ± 3.7 days) in group 1 compare with group 2 (P < .01).Compared with the survivors, the non-survivors showed higher serum ferritin and IL-6 levels, more rapidly progressive opacities in CT, lower oxygenation index, and longer mechanical ventilation durations. Special attention to ferritin/IL-6 levels and oxygenation index as well as early CT application and timely reexaminations are important to identify the individuals who may be at risk of becoming critically ill. 相似文献
88.
89.
目的探讨结直肠癌肝转移(CRLM)患者采用全腹腔镜与腹腔镜辅助同期切除术治疗的临床疗效比较。方法选取2010年2月至2015年4月间大连大学附属新华医院收治的68例CRLM同期切除患者,采用随机数表法分为辅助组和全镜组,每组34例。辅助组患者采用腹腔镜结直肠癌(CRC)根治术联合开腹CRLM切除术治疗,全镜组患者采用全腹腔镜切除术治疗,比较两组患者术中术后指标、术后并发症发生率及生存时间。结果两组患者手术时间和术中出血量比较,差异无统计学意义(P> 0.05)。两组患者术后排便时间和住院时间比较,差异无统计学意义(P>0.05)。辅助组患者并发症发生率为44.1%,全镜组为32.4%,差异无统计学意义(P> 0.05)。两组患者无病生存时间和总生存时间比较,差异无统计学意义(P> 0.05)。结论全腹腔镜与腹腔镜辅助同期切除术治疗CRLM患者的安全性及有效性结果接近,临床可根据患者病情合理选择手术方式。 相似文献
90.
肺癌是目前世界上发病率第二、死亡率第一的恶性肿瘤。非小细胞肺癌(NSCLC)是其主要病理类型,且易发生脑转移。目前,NSCLC脑转移的主要治疗方式包括手术、放疗、化疗、分子靶向治疗和免疫治疗等。放疗是脑转移局部治疗的常用方法,随着技术和药物的不断发展更新,放疗与其他治疗手段如何联合是目前临床研究热点。本文将对NSCLC脑转移放射治疗进展进行综述,从而为临床工作中治疗方案的选择提供参考。 相似文献